During the fibrosis process in malignant tumors, fibroblasts and CAFs are activated, leading to the secretion of significant amounts of pro-angiogenic factors, including vascular endothelial growth factor (VEGF), platelet-derived growth factor (PDGF), and basic fibroblast growth factor (bFGF). Here, FGF2 is linked to cancer.